{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:32:05Z","timestamp":1792024325788,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clineuro.2021.106844","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T18:50:42Z","timestamp":1628103042000},"page":"106844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review)"],"prefix":"10.1016","volume":"208","author":[{"given":"Haili","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2021.106844_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109602","article-title":"Synergy between plasminogen activator inhibitor-1, \u03b1-synuclein, and neuroinflammation in Parkinson\u2019s disease","volume":"138","author":"Reuland","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"8","key":"10.1016\/j.clineuro.2021.106844_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.clineuro.2021.106844_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2020-323939","article-title":"Prognostic predictors relevant to end-of-life palliative care in Parkinson\u2019s disease and related disorders: a systematic review","author":"Akbar","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.clineuro.2021.106844_bib4","doi-asserted-by":"crossref","first-page":"47387","DOI":"10.1371\/journal.pone.0047387","article-title":"Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum","volume":"7","author":"Lindqvist","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clineuro.2021.106844_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ene.13803","article-title":"Non-motor symptoms in early Parkinson\u2019s disease with different motor subtypes and their associations with quality of life","volume":"26","author":"Huang","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2021.106844_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000489311","article-title":"Association between white matter lesions and non-motor symptoms in Parkinson disease","volume":"18","author":"Lee","year":"2018","journal-title":"Neurodegener. Dis."},{"issue":"8","key":"10.1016\/j.clineuro.2021.106844_bib7","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s00415-018-8913-9","article-title":"Correlation among olfactory function, motors\u2019 symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson\u2019s disease","volume":"265","author":"Masala","year":"2018","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.clineuro.2021.106844_bib8","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1007\/s11064-020-03130-y","article-title":"Exploring the therapeutic potentials of highly selective oxygenated chalcone based MAO-B inhibitors in a haloperidol-induced murine model of Parkinson\u2019s disease","volume":"45","author":"Parambi","year":"2020","journal-title":"Neurochem. Res."},{"issue":"11","key":"10.1016\/j.clineuro.2021.106844_bib9","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/mds.27461","article-title":"Fatigue in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"33","author":"Siciliano","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.clineuro.2021.106844_bib10","doi-asserted-by":"crossref","first-page":"6372857","DOI":"10.1155\/2020\/6372857","article-title":"Fatigue and mental status of caregivers of severely chronically Ill patients","volume":"2020","author":"Kang","year":"2020","journal-title":"Pain Res. Manag."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106844_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10072-018-3695-5","article-title":"The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson\u2019s disease patients","volume":"40","author":"Dagklis","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2021.106844_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2019.05.028","article-title":"Fatigue in Parkinson\u2019s disease: Italian validation of the Parkinson fatigue scale and the fatigue severity scale using a Rasch analysis approach","volume":"65","author":"Siciliano","year":"2019","journal-title":"Park. Relat. Disord."},{"issue":"2","key":"10.1016\/j.clineuro.2021.106844_bib13","first-page":"164","article-title":"Clinical usefulness of fatigue severity scale for patients with fatigue, and anxiety or depression","volume":"9","author":"Chung","year":"2001","journal-title":"Korean J. Psychosom. Med."},{"key":"10.1016\/j.clineuro.2021.106844_bib14","first-page":"8624986","article-title":"Effects of vestibular rehabilitation on fatigue and activities of daily living in people with\u00a0Parkinson\u2019s disease: a pilot randomized controlled trial study","volume":"2020","author":"Abasi","year":"2020","journal-title":"Park. Dis."},{"key":"10.1016\/j.clineuro.2021.106844_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2016.09.030","article-title":"IL-6 serum levels are elevated in Parkinson\u2019s disease patients with fatigue compared to patients without fatigue","volume":"370","author":"Pereira","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.clineuro.2021.106844_bib16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s12035-015-9090-9","article-title":"The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases","volume":"53","author":"Morris","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106844_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10072-018-3695-5","article-title":"The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson\u2019s disease patients","volume":"40","author":"Dagklis","year":"2019","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.clineuro.2021.106844_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/mds.22989","article-title":"Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson\u2019s disease","volume":"25","author":"Friedman","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.clineuro.2021.106844_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.parkreldis.2004.07.007","article-title":"The Parkinson fatigue scale","volume":"11","author":"Brown","year":"2005","journal-title":"Park. Relat. Disord."},{"issue":"6","key":"10.1016\/j.clineuro.2021.106844_bib20","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/mds.1201","article-title":"Fatigue in Parkinson\u2019s disease: a nine-year follow-up","volume":"16","author":"Friedman","year":"2001","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.clineuro.2021.106844_bib21","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009381","article-title":"Inflammation and adaptive immunity in Parkinson\u2019s disease","volume":"2","author":"Mosley","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.clineuro.2021.106844_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12031-017-0942-9","article-title":"Role of apolipoproteins and \u03b1-synuclein in Parkinson\u2019s disease","volume":"62","author":"Emamzadeh","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.clineuro.2021.106844_bib23","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clineuro.2021.106844_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12916-014-0259-2","article-title":"Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses","volume":"13","author":"Morris","year":"2015","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.clineuro.2021.106844_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.clineuro.2021.106844_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson\u2019s disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.clineuro.2021.106844_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1741-7015-11-64","article-title":"A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and sickness behavior","volume":"11","author":"Morris","year":"2013","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106844_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11011-012-9324-8","article-title":"A neuro-immune model of Myalgic Encephalomyelitis\/Chronic fatigue syndrome","volume":"28","author":"Morris","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.clineuro.2021.106844_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","article-title":"Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease--associations with depression, fatigue, and cognitive impairment","volume":"33","author":"Lindqvist","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.clineuro.2021.106844_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10072-014-1976-1","article-title":"The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil\/lymphocyte ratio in Parkinson\u2019s disease","volume":"36","author":"Ak\u0131l","year":"2015","journal-title":"Neurol. Sci."},{"issue":"10","key":"10.1016\/j.clineuro.2021.106844_bib31","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.18632\/aging.101575","article-title":"Inflammation markers are associated with frailty in elderly patients with coronary heart disease","volume":"10","author":"Hou","year":"2018","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.clineuro.2021.106844_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.archger.2012.10.002","article-title":"Is increased red cell distribution width (RDW) indicating the inflammation in Alzheimer\u2019s disease (AD)?","volume":"56","author":"\u00d6zt\u00fcrk","year":"2013","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"7","key":"10.1016\/j.clineuro.2021.106844_bib33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.wnl.0000324862.29733.69","article-title":"Parkinson Study Group ELLDOPA Investigators, fatigue in levodopa-naive subjects with Parkinson disease","volume":"71","author":"Schifitto","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2021.106844_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/ene.13161","article-title":"Fatigue in early Parkinson\u2019s disease: the Norwegian ParkWest study","volume":"24","author":"Ongre","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"13","key":"10.1016\/j.clineuro.2021.106844_bib35","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/mds.26429","article-title":"Rasagiline for the symptomatic treatment of fatigue in Parkinson\u2019s disease","volume":"30","author":"Lim","year":"2015","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.clineuro.2021.106844_bib36","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/mds.26597","article-title":"Randomized, controlled trial of acupuncture for fatigue in Parkinson\u2019s disease","volume":"31","author":"Kluger","year":"2016","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.clineuro.2021.106844_bib37","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.2013.51.8860","article-title":"Yoga\u2019s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial","volume":"32","author":"Kiecolt-Glaser","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.clineuro.2021.106844_bib38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson\u2019s disease -- a randomized study","volume":"19","author":"Rios","year":"2013","journal-title":"Park. Relat. Disord."},{"issue":"6","key":"10.1016\/j.clineuro.2021.106844_bib39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jnnp.72.6.713","article-title":"Pramipexole in patients with Parkinson\u2019s disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study","volume":"72","author":"Pogarell","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721003735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721003735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:39:22Z","timestamp":1759588762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846721003735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":39,"alternative-id":["S0303846721003735"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106844","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review)","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106844"}}